| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.29 | 0.04 |